Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 19, 2010 - Issue sup1
Submit an article Journal homepage
67
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Expression of CD44V6 in parotid pleomorphic adenoma and carcinoma ex pleomorphic adenoma

Sen Yang Sichuan University, State Key Laboratory of Oral Diseases, Sichuan, China; Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Hong-Ping Wang Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Xiao-Yi Wang Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, 14, 3rd sec, Ren Min Nan Road, Chengdu 610041, Sichuan Province, PR China +86 28 85501455; +86 28 85582167; [email protected]
,
Li-Juan Guo Sichuan University, State Key Laboratory of Oral Diseases, Sichuan, China; Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Xiu-Fa Tang Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Qi-Hong Gao Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Ming Xuan Sichuan University, West China College of Stomatology, Department of Head and Neck in Surgical Oncology, Sichuan, China
,
Wings TY Loo UNIMED Medical Institute, Hong Kong; Organisation for Oncology and Translational Research, Hong Kong
&
Louis WC Chow UNIMED Medical Institute, Hong Kong; Organisation for Oncology and Translational Research, Hong Kong
 show all
Pages S101-S108 | Published online: 07 Apr 2010

Bibliography

  • Palacios E, Valvassori G. Parotid mass: pleomorphic adenoma(mixed tumour). Ear Nose Throat J 1999;78:746-7
  • Junquera L, Alonso D, Sampedro A, Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck 1999;21:652-6
  • Hou ZY, Wu LG, Yin K. Statistical analysis of 1878 salivary gland tumors according to new WHO classification [in Chinese]. J Mod Stomatol 1999;18:119-22
  • Duck SW, McConnel FM. Malignant degeneration of pleomorphic adenoma clinical implications. Am J Otolarygol 1993;14:175-8
  • Yusumoto M, Sunaba K, Shibuya H, Recurrent pleomorphic adenoma of the head and neck. Neuroradiol 1999;41:300-4
  • Qiu WL, Zhang ZK, Wang DZ. Oral and maxillofacial surgery theory and practice. Beijing: People's Health Press; 1998
  • Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol 1995;104:100-4
  • Stennert E, Wittekindt C, Klussmsnn JP, Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004;114:158-63
  • Henriksson G, Westrin KM, Carlsoo B, Recurrent primary pleomorphic adenomas of salivay gland origin intrasurgical rupture, histopathologic features, and pseudopodia. Cancer 1998;82:617-20
  • Valentini V, Fabiani F, Perugini M, Surgical techniques in the treatment of pleomorphic adenoma of the parotid gland: our experience and review of literature. J Craniofac Surg 2001;12:565-8
  • Lu WR, Fang YP, Ping JL. The relationship between capsule status and clinic of the pleomorphic adenoma of parotid gland [in Chinese]. Stomatology 1999;19:41-2
  • Okamoto H, Tsuruta Y, Miyahara H, Flow cytometric analysis of proliferative activity of pleomorphic adenoma of salivary gland. Nippon Jibiinkoka Gakkai Kaiho 1998;101:849-55
  • Zhu S, Wang X, Shao L, Flow cytometric analysis of DNA content in parotid tumour and its contiguous acini. J Tongji Med Univ 2000;20:86-8
  • Wen Y, Chen R, Wang C. The pathologic basis of partial parotidectomy in parotid pleomorphic adenoma treatment. Hua Xi Kou Qiang Yi Xue Za Zhi 2003;21:359-60
  • Heider KH, Sproll M, Susani S, Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas. Cancer Immunol Immunother 1996;43:245-53
  • Sandstrom K, Nestor M, Ekberg T, Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibody. Tumour Biol 2008;29:137-44
  • Günthert U, Hofmann M, Rudy W, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24
  • Chaiyarit P, Kafrawy AH, Miles DA, Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis. J Oral Pathol Med 1999;28:210-15
  • Joo M, Lee HK, Kang YK. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Anticancer Res 2003;23:1581-8
  • Ayhan A, Tok EC, Bildirici I, Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance. Gynecol Oncol 2001;80:355-8
  • Tamiolakis D, Kotini A, Cheva A, Gains and losses of glycoprotein CD44 and secretory component expression in endometrial hyperplasia and neoplasia. Eur Gynaecol Oncol 2002;23:453-6
  • Wu SB, Shi GS, Lu J. The expression and significance of CD44V6 in oral squamous cell carcinoma and the process of carcinogenesis [in Chinese]. Stomatology 2001;21:65-6
  • Bahar R, Kunishi M, Kayada Y, CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Maxillofac Surg 1997;26:443-6
  • Franchi A, Moroni M, Paglierani M, Expression of CD44 standard and variant isoforms in parotid gland and parotid gland tumours. J Oral Pathol Med 2001;30:564-8
  • Yuan RT, Ji XR, Sun XL, The expression of CD44v6 in pleomorphic adenoma and its malignant transformation [in Chinese]. J Mod Stomatol 2001;15:420-2
  • Qin RH, Cheng B, Chen XH, Li RY. Pathological significance and technique for detection of CD44v6 expression in salivary gland tumours [in Chinese]. Acad J Sun Yat-Sen Univ Med Sci 2000;21:316-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.